|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
29,740,000 |
Market
Cap: |
30.93(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.98 - $21.53 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AN2 Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients with rare infectious diseases. Co.'s initial product candidate, epetraborole, an antibiotic under development as a once-daily, oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
1,500,000 |
1,500,000 |
1,500,000 |
3,287,778 |
Total Buy Value |
$1,560,000 |
$1,560,000 |
$1,560,000 |
$17,613,772 |
Total People Bought |
1 |
1 |
1 |
3 |
Total Buy Transactions |
1 |
1 |
1 |
3 |
Total Shares Sold |
3,525,094 |
3,525,094 |
4,074,845 |
4,182,349 |
Total Sell Value |
$3,807,102 |
$3,807,102 |
$13,786,209 |
$15,496,714 |
Total People Sold |
1 |
1 |
7 |
7 |
Total Sell Transactions |
1 |
1 |
25 |
51 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Easom Eric |
Chief Executive Officer |
|
2022-11-07 |
4 |
AS |
$15.90 |
$195,741 |
D/D |
(12,203) |
4,907 |
|
-44% |
|
Easom Eric |
Chief Executive Officer |
|
2022-11-04 |
4 |
AS |
$15.80 |
$139,474 |
D/D |
(8,828) |
17,110 |
|
-46% |
|
Easom Eric |
Chief Executive Officer |
|
2022-11-03 |
4 |
AS |
$15.67 |
$223,058 |
D/D |
(14,165) |
25,938 |
|
-44% |
|
Easom Eric |
Chief Executive Officer |
|
2022-11-02 |
4 |
AS |
$15.07 |
$23,263 |
D/D |
(1,544) |
4,907 |
|
-47% |
|
Easom Eric |
Chief Executive Officer |
|
2022-10-31 |
4 |
AS |
$15.39 |
$41,363 |
D/D |
(2,688) |
6,451 |
|
-43% |
|
Easom Eric |
Chief Executive Officer |
|
2022-10-26 |
4 |
AS |
$15.10 |
$25,342 |
D/D |
(1,678) |
4,907 |
|
-42% |
|
Easom Eric |
Chief Executive Officer |
|
2022-10-25 |
4 |
AS |
$15.69 |
$75,672 |
D/D |
(4,806) |
6,585 |
|
-42% |
|
Easom Eric |
Chief Executive Officer |
|
2022-10-24 |
4 |
AS |
$16.17 |
$46,344 |
D/D |
(2,866) |
11,391 |
|
-42% |
|
Easom Eric |
Chief Executive Officer |
|
2022-10-21 |
4 |
AS |
$16.29 |
$228,240 |
D/D |
(13,951) |
4,907 |
|
-42% |
|
Easom Eric |
Chief Executive Officer |
|
2022-10-20 |
4 |
AS |
$16.68 |
$121,672 |
D/D |
(7,293) |
18,858 |
|
-42% |
|
Shah Rajeev M. |
10% Owner |
|
2022-08-04 |
4 |
B |
$7.99 |
$799 |
I/I |
100 |
3,773,517 |
1.42 |
13% |
|
Shah Rajeev M. |
10% Owner |
|
2022-08-03 |
4 |
B |
$7.48 |
$13,531 |
I/I |
1,809 |
3,773,417 |
1.5 |
20% |
|
Shah Rajeev M. |
10% Owner |
|
2022-07-27 |
4 |
B |
$7.91 |
$65,503 |
I/I |
8,281 |
3,771,608 |
1.5 |
9% |
|
Shah Rajeev M. |
10% Owner |
|
2022-07-26 |
4 |
B |
$7.71 |
$115,172 |
I/I |
14,938 |
3,763,327 |
1.5 |
15% |
|
Shah Rajeev M. |
10% Owner |
|
2022-06-21 |
4 |
B |
$7.99 |
$2,413 |
I/I |
302 |
3,748,389 |
1.42 |
- |
|
Shah Rajeev M. |
10% Owner |
|
2022-06-14 |
4 |
B |
$7.97 |
$489,402 |
I/I |
61,424 |
3,748,087 |
1.5 |
- |
|
Shah Rajeev M. |
10% Owner |
|
2022-06-13 |
4 |
B |
$7.90 |
$158,000 |
I/I |
20,000 |
3,686,663 |
1.5 |
- |
|
Adjuvant Capital Management, Llc |
10% Owner |
|
2022-06-06 |
4 |
A |
$15.00 |
$397,665 |
I/I |
26,511 |
413,156 |
|
- |
|
Adjuvant Capital Management, Llc |
10% Owner |
|
2022-06-06 |
4 |
D |
$15.00 |
$397,665 |
D/D |
(26,511) |
2,184,224 |
|
- |
|
Aziz Kabeer |
Director |
|
2022-06-06 |
4 |
A |
$15.00 |
$397,665 |
I/I |
26,511 |
413,156 |
|
- |
|
Aziz Kabeer |
Director |
|
2022-06-06 |
4 |
D |
$15.00 |
$397,665 |
I/I |
(26,511) |
2,184,224 |
|
- |
|
Adjuvant Capital Management, Llc |
10% Owner |
|
2022-03-29 |
4/A |
B |
$15.00 |
$2,499,990 |
D/D |
166,666 |
2,210,735 |
2.45 |
- |
|
Adjuvant Capital Management, Llc |
10% Owner |
|
2022-03-29 |
4/A |
A |
$0.00 |
$0 |
I/I |
386,645 |
386,645 |
|
- |
|
Adjuvant Capital Management, Llc |
10% Owner |
|
2022-03-29 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,044,069 |
2,044,069 |
|
- |
|
Readnour Robin Shane |
Director |
|
2022-03-29 |
4 |
B |
$15.00 |
$2,300,010 |
I/I |
153,334 |
487,592 |
2.1 |
- |
|
88 Records found
|
|
Page 3 of 4 |
|
|